Chicago, IL (PRWEB) March 26, 2015
Our goal at NIN Ventures is to invest in disruptive technologies. With that in mind, we are pleased to announce that Dr. Sunil Patel has joined NIN Ventures to be on the Advisory Board and also as a Venture Partner. Dr. Patel will be responsible for spearheading 3D Printing investments at NIN Ventures.
Dr. Patel is a multi-organ transplant surgeon at the University at Buffalo. His research interest includes tissue engineering and 3D printable materials. Dr. Patel has been a practicing physician for over 20 years. He studied medicine at University of Pune, trained at Mayo Clinic, Lehigh Valley Hospital / Penn State, and completed his fellowship from University of Pittsburgh.
“3D Printing has been used for rapid prototyping and is being applied in a number of industries today, including manufacturing, automotive, consumer, aerospace, defense, and especially healthcare. As the accuracy and materials market have improved, the medical space shows great potential for this technology. It’s time for the world to embrace personalized medicine,” said Dr. Patel.
“We welcome Dr. Patel to our Board of Advisor. We have great faith in Dr. Patel’s contribution to the 3D Printing industry and believe his research will strengthen our position in identifying key technologies especially in the medical space,” said Nin Desai, CEO of NIN Ventures.
About NIN Ventures
NIN Ventures (or NIN.VC) is a first of its kind technology venture capital fund to be raised via World Wide Web. NIN.VC is a unique web-based opportunity for Accredited Investors to invest in a venture capital fund with a minimum investment of $100,000. NIN Ventures invests in early / growth stage financial services technology, education software, internet and digital media, mobile communication, cloud computing, 3D printing, and other path-breaking technology companies in the United States.